1
|
Gaffan J, Dacre J and Jones A: Educating
undergraduate medical students about oncology: A literature review.
J Clin Oncol. 24:1932–1939. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Bollet MA, Sigal-Zafrani B, Mazeau V,
Savignoni A, de la Rochefordière A, Vincent-Salomon A, Salmon R,
Campana F, Kirova YM, Dendale R and Fourquet A: Age remains the
first prognostic factor for loco-regional breast cancer recurrence
in young (<40 years) women treated with breast conserving
surgery first. Radiother Oncol. 82:272–280. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hanahan D and Coussens LM: Accessories to
the crime: Functions of cells recruited to the tumor
microenvironment. Cancer Cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Wang Z and Ouyang G: Periostin: A bridge
between cancer stem cells and their metastatic niche. Cell Stem
Cell. 10:111–112. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhang Y, Zhang G, Li J, Tao Q and Tang W:
The expression analysis of periostin in human breast cancer. J Surg
Res. 160:102–106. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Malanchi I, Santamaria-Martínez A, Susanto
E, Peng H, Lehr HA, Delaloye JF and Huelsken J: Interactions
between cancer stem cells and their niche govern metastatic
colonization. Nature. 481:85–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kyutoku M, Taniyama Y, Katsuragi N,
Shimizu H, Kunugiza Y, Iekushi K, Koibuchi N, Sanada F, Oshita Y
and Morishita R: Role of periostin in cancer progression and
metastasis: Inhibition of breast cancer progression and metastasis
by anti-periostin antibody in a murine model. Int J Mol Med.
28:181–186. 2011.PubMed/NCBI
|
8
|
Xiao ZM, Wang XY and Wang AM: Periostin
induces chemoresistance in colon cancer cells through activation of
the pi3k/akt/survivin pathway. Biotechnol Appl Biochem. 62:401–406.
2015. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Sung PL, Jan YH, Lin SC, Huang CC, Lin H,
Wen KC, Chao KC, Lai CR, Wang PH, Chuang CM, et al: Periostin in
tumor microenvironment is associated with poor prognosis and
platinum resistance in epithelial ovarian carcinoma. Oncotarget.
7:4036–4047. 2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Xu D, Xu H, Ren Y, Liu C, Wang X, Zhang H
and Lu P: Cancer stem cell-related gene periostin: A novel
prognostic marker for breast cancer. PLoS One. 7:e466702012.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Nuzzo PV, Rubagotti A, Argellati F, Di
Meglio A, Zanardi E, Zinoli L, Comite P, Mussap M and Boccardo F:
Prognostic value of preoperative serum levels of periostin (PN) in
early breast cancer (BCa). Int J Mol Sci. 16:17181–17192. 2015.
View Article : Google Scholar : PubMed/NCBI
|
12
|
American Joint Committee on Cancer: Cancer
Staging Handbook: From the AJCC Cancer Staging Manual. Edge SB,
Byrd DR, Compton CC, Fritz AG, Greene F and Trotti A: 7th edition.
Springer-Verlag; New York: pp. 3472010
|
13
|
Lakhani SR, Ellis IO, Schnitee SJ, Tan PH
and van de Vijver MJ: WHO Classification of Tumours of the Breast.
4. 4th. IARC Press; Lyon: 2012
|
14
|
Diallo-Danebrock R, Ting E, Gluz O, Herr
A, Mohrmann S, Geddert H, Rody A, Schaefer KL, Baldus SE, Hartmann
A, et al: Protein expression profiling in high-risk breast cancer
patients treated with high-dose or conventional dose-dense
chemotherapy. Clin Cancer Res. 13:488–497. 2007. View Article : Google Scholar : PubMed/NCBI
|
15
|
Gebski V, Lagleva M, Keech A, Simes J and
Langlands AO: Survival effects of postmastectomy adjuvant radiation
therapy using biologically equivalent doses: A clinical
perspective. J Natl Cancer Inst. 98:26–38. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Rosen JM and Jordan CT: The increasing
complexity of the cancer stem cell paradigm. Science.
324:1670–1673. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Lagadec C, Vlashi E, Della Donna L,
Dekmezian C and Pajonk F: Radiation-induced reprogramming of breast
cancer cells. Stem Cells. 30:833–844. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Phillips TM, McBride WH and Pajonk F: The
response of cd24−/low/cd44+ breast
cancer-initiating cells to radiation. J Natl Cancer Inst.
98:1777–1785. 2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Duru N, Fan M, Candas D, Menaa C, Liu HC,
Nantajit D, Wen Y, Xiao K, Eldridge A, Chromy BA, et al:
HER2-associated radioresistance of breast cancer stem cells
isolated from HER2-negative breast cancer cells. Clin Cancer Res.
18:6634–6647. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Rycaj K and Tang DG: Cancer stem cells and
radioresistance. Int J Radiat Biol. 90:615–621. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Lambert AW, Wong CK, Ozturk S, Papageorgis
P, Raghunathan R, Alekseyev Y, Gower AC, Reinhard BM, Abdolmaleky
HM and Thiagalingam S: Tumor cell-derived periostin regulates
cytokines that maintain breast cancer stem cells. Mol Cancer Res.
14:103–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ben QW, Zhao Z, Ge SF, Zhou J, Yuan F and
Yuan YZ: Circulating levels of periostin may help identify patients
with more aggressive colorectal cancer. Int J Oncol. 34:821–828.
2009.PubMed/NCBI
|
23
|
Hong L, Sun H, Lv X, Yang D, Zhang J and
Shi Y: Expression of periostin in the serum of nsclc and its
function on proliferation and migration of human lung
adenocarcinoma cell line (a549) in vitro. Mol Biol Rep.
37:2285–2293. 2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Lv Y, Wang W, Jia WD, Sun QK, Huang M,
Zhou HC, Xia HH, Liu WB, Chen H, Sun SN and Xu GL: High
preoparative levels of serum periostin are associated with poor
prognosis in patients with hepatocellular carcinoma after
hepatectomy. Eur J Surg Oncol. 39:1129–1135. 2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Sasaki H, Yu CY, Dai M, Tam C, Loda M,
Auclair D, Chen LB and Elias A: Elevated serum periostin levels in
patients with bone metastases from breast but not lung cancer.
Breast Cancer Res Treat. 77:245–252. 2003. View Article : Google Scholar : PubMed/NCBI
|